Green Cross Holdings Corporation (005250.KS) KSC

15,650.00

-620(-3.81%)

Updated at September 26 03:30PM

Currency In KRW

Green Cross Holdings Corporation

Address

107, Ihyeon-ro 30beon-gil

Yongin-Si,

Korea, Republic of

Phone

82 3 1260 9300

Sector

Healthcare

Industry

Biotechnology

Employees

151

First IPO Date

January 04, 2000

Key Executives

NameTitlePayYear Born
Mr. Il-Sup Huh Ph.D.Chairperson and Chief Executive Officer01954
Mr. Yong-Jun HuhVice President and Director01974
Dr. Eun Chul HuhPresident0N/A
Mr. Yong-jun HurVice President & Director01974

Description

Green Cross Holdings Corporation operates as a biotechnology company. The company provides plasma derivatives, prescription drugs, over the counter drugs, and hunter syndrome drugs; and vaccines for hemorrhagic fever, varicella, hepatitis-B, and flu. It also researches and develops oncology, immunology, and cell therapy products; and offers recombinant protein treatment for hemophilia. The company has partnerships and collaborations with biotech companies and academia for development of new drugs and technologies. Green Cross Holdings was founded in 1967 and is headquartered in Yongin, South Korea.